Next Article in Journal
Hypervalent Iodine
Previous Article in Journal / Special Issue
Biodegradable Polymers for Microencapsulation of Drugs
Molecules 2005, 10(1), 162-180; doi:10.3390/10010162
Review

Optimization of Protein Therapies by Polymer-Conjugation as an Effective DDS

1, 1 and 1,*
Received: 30 June 2004 / Revised: 27 September 2004 / Accepted: 12 December 2004 / Published: 31 January 2005
(This article belongs to the Special Issue Macromolecules Applied to Pharmaceutical Chemistry)
Download PDF [319 KB, uploaded 18 June 2014]

Abstract

Due to recent advances in disease proteomics, many disease-related proteins have been found. It is expected that there will be therapeutically useful proteins among them. However, it is clinically difficult to use most proteins as effective and safe drugs because of their very low stability and pleiotropic actions in vivo. To promote disease proteomic based drug development for protein therapies, we have attempted to develop an optimal polymer-conjugation system for improving the therapeutic potency of proteins. In this review, we introduce this innovative protein-drug system.
Keywords: PEGylation; polyvinyl pyrrolidone; Tumor necrosis factor-alpha; Interluekin-6. PEGylation; polyvinyl pyrrolidone; Tumor necrosis factor-alpha; Interluekin-6.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Shibata, H.; Nakagawa, S.; Tsutsumi, Y. Optimization of Protein Therapies by Polymer-Conjugation as an Effective DDS. Molecules 2005, 10, 162-180.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert